PBK_L2201

· Pharmbio Korea Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PBK_L2201, covering 2023-12-04 to 2023-12-04. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of PBK_L2201 in Postmenopausal Women With Osteoporosis [Phase 3]